Vital Therapies (VTL) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts VTL Hot Sheet
Join SI Premium – FREE
Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- PG&E launches strategic review, defers $2B in 2027 capital spending
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
